KYTOSIA Trademark

Trademark Overview


On Wednesday, June 22, 2022, a trademark application was filed for KYTOSIA with the United States Patent and Trademark Office. The USPTO has given the KYTOSIA trademark a serial number of 97469786. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, September 12, 2023. This trademark is owned by Cellarity, Inc.. The KYTOSIA trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical agents, therapeutics and preparations for the treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders; pharmaceutical compositions in the nature of chemical small molecules for treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders

Diagnostic and screening services, namely, conducting diagnostic testing and evaluation of molecules developed through artificial intelligence means for the combatting of diseases

Bioinformatic services for scientific research purposes, namely, collecting and analyzing complex biological data through the use of artificial intelligence; computer assisted molecule design involving the use of artificial intelligence technology; drug discovery services; pharmaceutical research and development services; scientific research and development of pharmaceutical preparations; providing on-line non-downloadable software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable software featuring machine learning and artificial intelligence for data analysis in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable software featuring machine learning and artificial intelligence for drug analysis in drug discovery and de...
kytosia

General Information


Serial Number97469786
Word MarkKYTOSIA
Filing DateWednesday, June 22, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, September 12, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 18, 2023

Trademark Statements


Goods and ServicesPharmaceutical agents, therapeutics and preparations for the treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders; pharmaceutical compositions in the nature of chemical small molecules for treatment of cancer, autoimmune disorders, transplant rejections, inflammatory disease, immunological disorders, metabolic disorders, neurological disorders, genetic disorders, psychiatric disorders, gastroenterological disorders, renal disorders, cardiovascular disorders, dermatological disorders, respiratory disorders
Goods and ServicesDiagnostic and screening services, namely, conducting diagnostic testing and evaluation of molecules developed through artificial intelligence means for the combatting of diseases
Goods and ServicesBioinformatic services for scientific research purposes, namely, collecting and analyzing complex biological data through the use of artificial intelligence; computer assisted molecule design involving the use of artificial intelligence technology; drug discovery services; pharmaceutical research and development services; scientific research and development of pharmaceutical preparations; providing on-line non-downloadable software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable software featuring machine learning and artificial intelligence for data analysis in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable software featuring machine learning and artificial intelligence for drug analysis in drug discovery and development; scientific research, namely, research and analysis services in the scientific fields of artificial intelligence and machine learning analytics, healthcare, biomedical and genomic research; providing on-line non-downloadable software incorporating artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, effects and risks

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, July 9, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 14, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 6, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCellarity, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSomerville, MA 02143

Party NameCellarity, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSomerville, MA 02143

Trademark Events


Event DateEvent Description
Tuesday, September 12, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 18, 2023PUBLISHED FOR OPPOSITION
Wednesday, June 28, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 14, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 14, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, June 14, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 14, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, June 14, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 23, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, February 23, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, December 5, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 5, 2022NON-FINAL ACTION E-MAILED
Monday, December 5, 2022NON-FINAL ACTION WRITTEN
Thursday, October 20, 2022ASSIGNED TO EXAMINER
Saturday, July 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED